Novel Agents and Management Strategies in Endocrinology

• Series Overview
• Program Content
• Faculty
• Target Audience and Program Goals
• CPE Credit
• BCPS/BCACP Specialty Recertification Credit
• Technical Requirements
• Fees

From Theory to Practice : Clinical Reasoning Series in Ambulatory Care Pharmacy is one component of the professional development program developed by ACCP and approved by the Board of Pharmacy Specialties (BPS) for the recertification of the Board Certified Ambulatory Care Pharmacist (BCACP). The 2015 program is also approved by BPS for the recertification of the Board Certified Pharmacotherapy Specialist (BCPS). Clinical pharmacists who are board certified in both the pharmacotherapy and ambulatory care pharmacy specialties and who successfully complete the associated recertification test will receive credit toward recertification in both specialties.

This educational series explores cutting-edge, contemporary therapeutic topics, and demonstrates scientifically sound clinical reasoning and decision-making. It employs learning activities designed to advance the participants’ skills and abilities to critically evaluate the scientific evidence and to effectively incorporate into daily practice significant findings that lead to effective and safe patient care.

“Novel Agents and Management Strategies in Endocrinology” provides a critical review of the clinical evidence on the various agents approved for the management of type 2 diabetes and obesity, and discuss implications on pharmacist patient-care services.

“Novel Agents and Management Strategies in Endocrinology” covers the following content:

• Type 2 Diabetes: Critical Review of the Evidence and Application to Patient Care
• First-in-class, Novel, and New Drugs and Delivery Systems for the Management of Type 2 Diabetes
• Obesity: New Management Strategies
• Practice Management and Pharmacist Services
• Patient Cases

	Benjamin N. Gross, Pharm.D., BCPS, BCACP, CDE, BC-ADM Associate Professor Lipscomb University College of Pharmacy and Health Sciences Nashville, Tennessee
	Emily McCoy Armstrong, Pharm.D., BCACP Assistant Clinical Professor Auburn University Harrison School of Pharmacy Mobile, Alabama
	M. Shawn McFarland, Pharm.D., FCCP, BCPS, BCACP Associate Service Chief of Pharmacy Clinical & Educational Programs VA Tennessee Valley Healthcare System Associate Professor University of Tennessee College of Pharmacy Murfreesboro, Tennessee
	Jennifer M. Trujillo, Pharm.D., BCPS, CDE Associate Professor University of Colorado Anschutz Medical Campus Skaggs School of Pharmacy & Pharmaceutical Sciences Aurora, Colorado

The target audience for this program is clinical pharmacists, BCACPs and BCPSs providing care to patients with type 2 diabetes and obesity.

At the conclusion of the program, the participant should be able to:

1. Compare and contrast the various agents approved for the management of type 2 diabetes and obesity.
2. Critically appraise the published evidence on the treatment of patients with type 2 diabetes and obesity.
3. Given a patient case, recommend a management plan for type 2 diabetes and obesity.
4. Employ strategies to advance pharmacist services.

The American College of Clinical Pharmacy is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.

This is an application-based activity; Activity Number: 0217-0000-15-110-H01-P.

To earn continuing pharmacy education (CPE) credit and to receive your continuing pharmacy education statement of credit for this activity, participants must successfully complete a Web-based posttest by October 14, 2018. Partial credit is not available for this activity.

To be eligible for 6.0 CPE hours of recertification credit, BCACPs and BCPSs must successfully complete a Web-based posttest by November 30, 2015. Partial credit is not available for this activity.

ACCP, as the official provider approved by BPS, will record and report recertification credit earned for this activity directly to BPS.

Requires an Internet browser and Adobe Reader.